Lo Dico Alessia

Type B Postdoctoral Fellow

Contacts

Workplace

Via Fratelli Cervi, 93 - L.I.T.A. Segrate
20090 SEGRATE (MI)

University email address
Research

Publications

Publications
  • Theranostic application of miR-429 in HER2+ breast cancer / C. Cava, C. Novello, C. Martelli, A. Lo Dico, L. Ottobrini, F. Piccotti, M. Truffi, F. Corsi, G. Bertoli, I. Castiglioni. - In: THERANOSTICS. - ISSN 1838-7640. - 10:1(2020 Jan), pp. 50-61.
  • Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma / A. Lo Dico, D. Salvatore, C. Martelli, D. Ronchi, C. Diceglie, G. Lucignani, L. Ottobrini. - In: CELLS. - ISSN 2073-4409. - 8:11(2019 Oct 24), pp. 1315.1-1315.17.
  • PET biomarkers and probes for treatment response assessment in glioblastoma : a work in progress / D. Salvatore, A. Lo Dico, C. Martelli, C. Diceglie, L. Ottobrini. - In: CLINICAL AND TRANSLATIONAL IMAGING. - ISSN 2281-5872. - 7:4(2019 Aug), pp. 285-294.
  • Role of metformin and AKT axis modulation in the reversion of hypoxia induced TMZ-resistance in glioma cells / A. Lo Dico, S. Valtorta, L. Ottobrini, R.M. Moresco. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 9(2019 May 31), pp. 463.1-463.10.
  • Hypoxia-inducible factor-1α activity as a switch for glioblastoma responsiveness to temozolomide / A. Lo Dico, C. Martelli, C. Diceglie, G. Lucignani, L. Ottobrini. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 8(2018 Jul 02), pp. 249.1-249.11.